Brief: Peptidream Inc - Announces New Research And Collaboration Agreement With Eli Lilly For The Discovery Of Novel Peptide Drug Conjugates
26/12/2022 07:35
Dec 26 (Reuters) - PeptiDream Inc 4587.T :
* ANNOUNCES NEW RESEARCH AND COLLABORATION AGREEMENT WITH
ELI
LILLY FOR THE DISCOVERY OF NOVEL PEPTIDE DRUG CONJUGATES
Source text for Eikon: ID:nTSxz8e883
Further company coverage: 4587.T
Recent news on PeptiDream
See all newsTable: Peptidream 6-MTH group results (IFRS)
Brief: Peptidream Inc. - Initiation Of Phase 1 Clinical Trial By Novartis Marks Milestone For Peptidream
Brief: PeptiDream Announces First Dosing Of 64cu-Pd-29,875 In Gastric Cancer Patients
Table: Peptidream -Q1 group results (IFRS)
Brief: Peptidream Announces The Initiation Of Phase 1 Clinical Trial By Its Collaboration Partner